Article
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
Oncotarget - 2 May 2017
Luatti Simona, Baldazzi Carmen, Marzocchi Giulia, Ameli Gaia, Bochicchio Maria Teresa, Soverini Simona, Castagnetti Fausto, Tiribelli Mario, Gugliotta Gabriele, Martinelli Giovanni, Baccarani Michele, Cavo Michele, Rosti Gianantonio, Testoni Nicoletta
Abstract excerpt
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph), despite the presence of the BCR/ABL rearrangement. Two mechanisms have been proposed about the occurrence of this rearrangement: the first one is a cryptic insertion between chromosomes 9 and 22; the second one involves two sequential translocations: a classic t(9;22) followed by a reverse translocation, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
